Crown Bioscience, a global drug discovery and development service company providing translational platforms to advance oncology and metabolic disease research, hosted a symposium earlier this month for some of the industry’s leading experts to discuss the latest scientific discoveries in translational oncology. “Some of the foremost researchers in this field shared information about immuno-oncology therapies and their impact on translational oncology,” said Christopher Murriel, who chaired the ...